Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)

Clinical trial NCT00300118 · COMPLETED

Trial details

NCT number: NCT00300118
Sponsor: Dr. Falk Pharma GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2004-09-01
Primary completion: 2008-05-01
Enrollment: 311

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.